WB result of Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: 293T whole cell lysate 20 µg
Lane 2: 293T whole cell lysate 20 µg (phosphatase treated membrane)
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 52 kDa
Observed MW: 52, 56 kDa
Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb (S-3372-136)
Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb (S-3372-136)
Price:
Regular price
$100 USD
Regular price
Sale price
$100 USD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | Phospho-SMAD2/3 (Thr8) |
| Synonyms | SMAD family member 2; hSMAD2; JV18-1; Mad-related protein 2 (hMAD-2); Mothers against decapentaplegic homolog 2 (MAD homolog 2; Mothers against DPP homolog 2); MADH2; MADR2; SMAD family member 3; hSMAD3; JV15-2; Mothers against decapentaplegic homolog 3 (MAD homolog 3; Mad3; Mothers against DPP homolog 3; hMAD-3); MADH3 |
| Immunogen | Synthetic Peptide |
| Location | Cytoplasm, Nucleus |
| Accession | Q15796、P84022 |
| Clone Number | S-3372-136 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB |
| Reactivity | Hu, Ms, Rt |
| Positive Sample | 293T, RAW264.7, PC-12 |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| WB | 1:1000 | Hu, Ms, Rt |
Background
Phospho-SMAD2/3 (Thr8) refers to the phosphorylation of SMAD2 and SMAD3 proteins at threonine 8, a site distinct from their canonical C-terminal SXS motif phosphorylation by TGF-β receptors. This alternative phosphorylation is typically mediated by MAP kinases (ERK, JNK, p38) or CDKs in response to various stimuli including growth factors, stress, and cell cycle signals. It modulates SMAD transcriptional activity, stability, and subcellular localization, serving as a regulatory crossroad between TGF-β signaling and other pathways. Aberrant Thr8 phosphorylation has been implicated in cancer progression and fibrotic diseases, influencing cell proliferation, migration, and epithelial-mesenchymal transition.
Picture
Picture
Western Blot
WB result of Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: RAW264.7 whole cell lysate 20 µg
Lane 2: RAW264.7 whole cell lysate 20 µg (phosphatase treated membrane)
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 52 kDa
Observed MW: 56 kDa
WB result of Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Primary antibody: Phospho-SMAD2/3 (Thr8) Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: PC-12 whole cell lysate 20 µg
Lane 2: PC-12 whole cell lysate 20 µg (phosphatase treated membrane)
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 52 kDa
Observed MW: 56 kDa
